Athersys

About:

Athersys is a biopharmaceutical company that discovers and develops therapeutic products to treat several disease indications.

Website: http://www.athersys.com

Twitter/X: athersys

Top Investors: RA Capital Management, OrbiMed, William Blair, MPM Capital, First Analysis

Description:

Athersys is a biopharmaceutical company that discovers and develops therapeutic products to treat several disease indications. The company's product development portfolio includes MultiStem, a stem cell product, that is being developed as a treatment for multiple disease indications, is being evaluated in two ongoing clinical trials, and has been authorized for use in a third clinical trial. In addition, Athersys develops pharmaceuticals to treat indications such as obesity, certain cognitive and attention disorders, narcolepsy, or other forms of excessive daytime sleepiness.

Total Funding Amount:

$209M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cleveland, Ohio, United States

Founded Date:

1995-01-01

Contact Email:

info(AT)athersys.com

Founders:

Gil Van Bokkelen, John Harrington

Number of Employees:

11-50

Last Funding Date:

2023-04-18

IPO Status:

Public

Industries:

© 2025 bioDAO.ai